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Curry–Jones syndrome (CJS) is a pattern of malformation that includes craniosynostosis,
pre-axial polysyndactyly, agenesis of the corpus callosum, cutaneous and gastrointestinal
abnormalities. A recurrent, mosaicmutation of SMO (c.1234C>T; p.Leu412Phe) causesCJS. This
report describes the gastrointestinal and surgical findings in a babywith CJSwho presentedwith
abdominal obstruction and reviews the spectrum of gastrointestinal malformations in this rare
disorder. A 41-week, 4,165 g, female presented with craniosynostosis, pre-axial polysyndactyly,
and cutaneous findings consistent with a clinical diagnosis of CJS. The infant developed
abdominal distension beginning on the second day of life. Surgical exploration revealed an
intestinal malrotation for which she underwent a Ladd procedure. Multiple small nodules were
foundon the surface of the small and large bowel in addition to an apparent intestinal duplication
that seemed to originate posterior to the pancreas. Histopathology of serosal nodules revealed
bundles of smooth muscle with associated ganglion cells. Molecular analysis demonstrated the
SMO c.1234 C>T mutation in varying amounts in affected skin (up to 35%) and intestinal
hamartoma (26%). Gastrointestinal features including structural malformations, motility
disorders, and upper GI bleeding are major causes of morbidity in CJS. Smooth muscle
hamartomas are a recognized feature of children with CJS typically presenting with abdominal
obstruction requiring surgical intervention. A somatic mutation in SMO likely accounts for the
structural malformations and predisposition to form bowel hamartomas and myofibromas. The
mutation burden in the involved tissues likely accounts for the variable manifestations.
K E YWORD S
Curry–Jones syndrome, gastrointestinal smooth muscle hamartomas, SMO somatic mosaic
mutations
1 | INTRODUCTION
Curry–Jones syndrome (CJS; OMIM #601707) is a pattern of malforma-
tion that includes craniosynostosis, pre-axial polysyndactyly, agenesis of
the corpus callosum, cutaneous and gastrointestinal abnormalities
(Temple et al., 1995). The first two cases were presented as unknown
syndromes at the David W. Smith workshop on malformations in 1987
(Curry, 1987). Cohen (1988) recognized the cases as a pattern of
malformation and termed theCJS after the physicianswhohad described
the first two cases. Eleven unrelated cases have been reported in the
literature presenting with craniofacial abnormalities, patchy cutaneous
findings, and polysyndactyly (Grange et al., 2008; Mingarelli, Mokini,
Castriota-Scanderbeg, & Dallapiccola, 19999; Temple et al., 1995;
Thomas et al., 2006; Twigg et al., 2016).
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Until recently, the genetic etiology of CJS was not known. All
cases of CJS occurred sporadically and karyotype analyses of blood
and fibroblasts from affected skin were normal. Based on clinical
observations including asymmetric features and patchy cutaneous
manifestation, it was hypothesized that CJS was due to a somatic
mutation arising in early post-zygotic embryonic development.
However, symmetric polydactyly and syndactyly was not consistent
with this hypothesis. Grange et al. (2008) reported two new children
with CJS including one child with a desmoplastic medulloblastoma
and another child with a trichoblastoma of the skin and thus
hypothesized that CJS may be due to a defect in the sonic hedgehog
(Shh) pathway. However, sequencing of PTCH and GLI, genes coding
for key proteins in the Shh signaling pathway, was negative.
Recently, Twigg et al. (2016) identified by whole exome sequencing
of affected skin, a somatic heterozygous variant in SMO (c.1234C>T;
p.Leu412Phe). This gene encodes the G-protein coupled receptor
smoothened which is involved in the HH-GLI signaling pathway. The
authors then identified varying amounts of the identical mutant
allele by deep sequencing of affected tissues in eight unrelated
individuals with CJS, providing additional evidence for the molecular
cause of CJS.
Gastrointestinal abnormalities are a cardinal feature of CJS.
Previously described findings include pseudo-obstruction, malrota-
tion, and gastrointestinal myofibromas or smooth muscle hamarto-
mas (Grange et al., 2008; Temple et al., 1995). Here, we present a
child with CJS who presented with abdominal distension in the
newborn period. This case, listed in table 1 of Twigg et al. (2016) as
case #10, was found to have the recurrent, mosaic mutation of SMO
(c.1234 C>T; p.Leu412Phe) that causes CJS. This report presents a
detailed clinical description and is accompanied with a more
complete molecular analysis. In addition we compare the gastroin-
testinal features with prior cases in the literature and discuss the
developmental pathophysiologic correlates to further delineate the
syndrome.
2 | CASE DESCRIPTION
The proband is a female infant born at 41weeks EGA to an 18-year-old
G1P0 Hispanic-Samoan mother and non-consanguineous 18-year-old
Hispanic father. The mother had routine prenatal care and there were
no significant exposures. Pregnancy was complicated by pyelectasis
and absent cavum septum pellucidum detected on ultrasound during
the second trimester fetal anatomy survey. Upon transfer of care at
35 weeks (after the family relocated), she was started on weekly non-
stress tests due to the presence of suspected fetal anomalies. A repeat
ultrasound obtained at 39 3/7 weeks GA showed accelerated fetal
growth (gestational age equivalents: biparietal diameter: 40 0/7
weeks, head circumference 40 6/7 weeks, abdominal circumference
39 6/7 weeks, femur length 37 1/7 weeks), and apparent fusion of the
anterior lateral ventricles, concerning for alobar holoprosencephaly.
The infant was delivered by cesarean section after a failed induction of
labor with Apgars of 9 and 9 at 1 and 5min, respectively. The infant
was large for gestational age with a birth weight of 4,165 g (96th
percentile, z-score 1.88), length of 53.3 cm (98th percentile, z-score
2.23), and occipitofrontal head circumference of 38.5 cm (∼100th
percentile, z-score 3.90) (WHO 0–2 years female growth chart).
The proband was noted to have multiple dysmorphic features at
birth (Figure 1). She hadmacrocephaly, fusion of the left coronal suture,
facial asymmetry with a hypoplastic left supra-orbital ridge and
contralateral frontal bossing, and flat occiput. The nasal bridge was
depressed with short, anteverted nares and the bulbous nasal tip
deviated to the right. The right ear was smaller than the left with an
irregular contour and redundant tissue. Ocular anomalies included
hypertelorismwith irregular contourof theeyelids,microphthalmia, and
inability to open the right eye spontaneously. Ectopic eyelashes were
noted on the upper eyelid. Dilated fundoscopic exam revealed sectoral
(partial) clouding of both corneas, right greater than left. The palate was
intact and the mandible was normal. There was pre-axial polydactyly
with bilateral partial duplication of the thumbs and great toes. A single
FIGURE 1 (a–c) Craniofacial, extremity, and cutaneous features in a newborn with Curry–Jones syndrome. Notable features include
asymmetric frontal bossing, hypoplastic left supraorbital ridge, right orbital dystopia and downward displacement of right palpebral fissure,
low nasal bridge, short nose with bulbous nasal tip. Profile of craniofacial features highlights a small right ear with irregular helical contour and
redundant tissue. Bilateral pre-axial polydactyly involving the great toe of right and left lower extremities. Patchy skin distribution with areas
of pigmentation and depigmentation and atrophic texture. [Color figure can be viewed at wileyonlinelibrary.com]
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transverse palmar creasewas present on the right hand. Examination of
the skin revealed thickened, marbled areas normally pigmented and
hypopigmented skin on the right trunk, and bilaterally on the lower
extremities (see right shoulder in Figure 1a and lower extremities in
Figure 1c). The skin had an atrophic, pebbly texture with patches of
abnormal hair on the extremities. The abdomenwas distended but soft
without palpable masses or organomegaly. The remainder of the
examination including respiratory, cardiovascular, genitourinary, and
neurologic systemswasunremarkable.Upon recognition, thedistinctive
pattern of cutaneous findings, craniosynostosis, and pre-axial poly-
syndactyly by an examiner (MCJ) with previous experience with CJS, a
clinical diagnosis of CJS was made in the proband.
Renal ultrasound revealed mild bilateral hydronephrosis and
cranial ultrasound suggested callosal agenesis. Subsequent brain MRI
revealed near-complete agenesis of the corpus callosum. Radiographs
of the upper extremities showed pre-axial polydactyly with osseus
syndactyly of the extra digit to the thumb and a short first metacarpal
on the right hand; the left hand also had pre-axial polysyndactyly.
Radiographs of the lower extremities showed bilateral pre-axial
polydactyly. CT scan of the head showed left coronal craniosynostosis
as well as multiple intrasutural bones being noted, similar to wormian
bones. A SNP-oligonucleotide microarray showed 46, XX without
pathogenic copy number variation.
On the fourth day of life, the patient was evaluated for decreased
oral intake followed by 1 day of bilious emesis and abdominal
distention. Upright abdominal radiographs revealed significant proxi-
mal bowel dilatation. She was decompressed with oral-gastric (OG)
suction and bowel rest with initial improvement in symptoms.
However, she continued to have bilious OG output in the absence
of bowel movements for multiple days. Serial abdominal radiographs
did not show obvious obstruction, although she had very delayed
transit of contrast through her bowel and rectum. Rectal biopsies were
obtained which revealed the presence of ganglion cells, effectively
ruling out Hirschsprung disease. Rare hypertrophic nerve bundles
were also noted on biopsy. After rectal biopsy, an upper GI
radiographic series with barium contrast revealed malrotation without
volvulus and delayed emptying of contrast through the cecum and
rectum.
On day 14, the infant underwent exploratory laparotomy and
Ladd procedure to address the malrotation. During laparotomy, the
patient was found to have a curvature at the duodenum that
appeared almost twisted but no Ladd bands crossing the small
bowel, and no obvious point of obstruction. Throughout the
abdomen on the mesentery and the surface of the bowel and
appendix were small tumors (Figure 2a). Formalin-fixed biopsies of
these tumors revealed smooth muscle bundles with intermyenteric
ganglion cell nests (Figure 3), a distinctive feature that provided
further confirmation of the diagnosis of CJS. Additionally, the
patient had a blind-ended tubular structure that appeared to
originate from behind the pancreas with increasing diameter
(1.5 cm) as it descended posteriorly, consistent in appearance with
a congenital intestinal duplication (Figure 2b). The postoperative
course was complicated by prolonged ileus and required parental
nutrition until the 27th day of life. The infant was discharged home
on full oral feeding after 45 hospital days.
Following NICU discharge, the infant had intermittent emesis,
poorweight gain on 24 kcal fortified formula, and chronic constipation.
She was admitted at 5 months of age for failure to thrive. The infant
was noted to have a focal area of esophageal narrowing just below the
level of the thoracic inlet on a modified barium swallow study. An
FIGURE 2 (a and b) Malrotation and small discrete nodules adherent to the small and large bowel. Congenital intestinal duplication
originating posterior to the pancreas. [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 3 (a and b) H&E staining of discrete mass from the cecal mesentery. Appearance at 200× magnification reveals intermyenteric
ganglion cells embedded in smooth muscle. Arrow indicates smooth muscle fibers. [Color figure can be viewed at wileyonlinelibrary.com]
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upper GI and small bowel series with barium contrast demonstrated
diffuse intestinal distension. Anorectal manometry revealed border-
line elevated resting pressure of the internal anal sphincter with
normal recto-ano inhibitory reflex. The esophageal pH study was
normal. A follow-up brain MRI demonstrated left cerebellar tonsillar
ectopia, near complete agenesis of the corpus callosum, colpocephaly,
increased size of the lateral and third ventricles, and a dysgenesis of
the tectal plate and delayedmyelination for age. The infant underwent
gastrostomy tube placement for dysmotility and poor weight gain.
Intraoperative findings included a markedly dilated transverse colon.
The infant was discharged home on continuous gastrostomy tube
feedings after 45 hospital days.
The infant was readmitted when shewas 8months old for feeding
intolerance and weight loss. Upon admission, this formerly macro-
somic infant had a weight for age less than the first percentile
(z = −3.32), length was less than the first percentile (z = −2.35), and
head circumference at the 73rd percentile (z = 0.63) on WHO growth
charts. She developed intermittent abdominal distension, emesis, and
irritability when gastrostomy feedings were advanced. A CT of the
abdomen and pelvis demonstrated diffuse colon dilatation without
obvious mechanical obstruction. The abdominal distension improved
with placement of a nasogastric tube. Based on the imaging findings,
the diagnosis of CJS, and known anatomical abnormalities from prior
procedures, the clinical picture was most likely to be caused by colonic
pseudo-obstruction. An ileostomy was recommended to manage
colonic pseudo-obstruction. However, after multiple meetings with
the family the parents declined the ileostomy. The infant was
discharged home with the family at 9 months on hospice care and
subsequently died.
3 | MOLECULAR STUDIES
Informed consent was obtained with an IRB-approved consent form
prior to participation in research. For analysis of SMO, we collected
normal and affected skin samples as well as formalin-fixed paraffin-
embedded (FFPE) sections of the intestinal smooth muscle hamar-
toma. Skin samples were placed in tissue culture dishes to isolate
fibroblasts and keratinocytes. After 2 days of culture, fibroblasts were
removed by trypsin digestion (and subsequently passaged twice
before analysis), while the keratinocytes (which surround the skin
sample) were harvested using a cell scraper. DNA was extracted from
skin (including isolated fibroblasts and keratinocytes) by Proteinase K
digestion followed by phenol/chloroform extraction and ethanol
precipitation, while DNA fromFFPEmaterial (five 10 μMsections) was
isolated using the QIAamp DNA FFPE Tissue kit (Qiagen). Cellular
identities of keratinocytes and fibroblasts were confirmed with
RT-PCR analysis of expression of the two distinguishing FGFR2
isoforms (IIIb is only expressed in keratinocytes while IIIc is only
expressed in fibroblasts, data not shown). The same mutant allele of
SMO (c.1234C>T, p.Leu412Phe) found in other cases of CJS (Twigg
et al., 2016) was identified. Figure 4 presents the distribution of
mutant and wild-type allele for affected and unaffected skin samples.
The mutant allele was found in both affected dermis (represented by
fibroblasts; T allele frequency 16.2%) and at a higher level in affected
epidermis (represented by keratinocytes; T allele frequency 34.7%).
Themutant T allelewaspresent also in unaffected dermis andepidermis
but at a lower level compared to affected skin. In the intestinal
hamartoma the mutant allele was present in 25.6% of the sample.
4 | DISCUSSION
Important insights into the clinical and molecular pathogenesis of CJS
can be drawn from the present case. From a molecular standpoint, a
recurrent mosaic mutation in SMO results in malformations of the
gastrointestinal tract and skin. Analyses of affected skin and intestinal
smooth muscle hamartoma show an increased frequency of the
mutant SMO allele compared with unaffected tissues. In all affected
tissues studied, the mutant allele is present at a frequency less than
50%, which reflects tissue mosaicism. Twigg et al. (2016) recently
identified a mosaic gain of function mutation in SMO (c.1234C>T,
p.Leu412Phe) in seven other cases with CJS inmultiple affected tissues
including skin, FFPE samples of medulloblastoma, intestinal myofi-
bromas, or smooth muscle hamartomas. Within the skin, the mutant
allele frequency varied with the phenotypic findings of the skin
FIGURE 4 Distribution of SMO c.1234C>T, p.Leu412Phe mutant T alleles in affected (red bars) and clinically unaffected (blue bars) tissues.
Dermis and epidermis layers are represented by cultured fibroblasts and keratinocytes, respectively. [Color figure can be viewed at
wileyonlinelibrary.com]
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(hyperpigmented or affected compared with unaffected) but also with
the layers of the skin. The factors that drive a higher mutant allele
frequency within the epidermis are unknown. In addition, detection of
the mutant allele within apparently unaffected skin at a low level
suggests that themutation arose early in skin development. Indeed, the
presence of mosaicism as well as detection of the mutant allele in
multiple different tissue types suggests that themutation occurred as a
post-zygotic error early in embryonic development.
SMO is a key component of the HH-GLI pathway and its protein
product, smoothened, is essential for normal HH signal transduction.
The HH-GLI pathway has widespread roles in embryonic development
(Briscoe & Thérond, 2013). Specifically, within the gastrointestinal
system, prior studies have demonstrated the role of the HH-GLI
pathway for cellular differentiation, tissue patterning, and axis
determination. (Hirokawa, Tanaka, Okada, & Takeda, 2006;
Ramalho-Santos, Melton, & McMahon, 2000; Shook & Keller, 2003).
Congenital gastrointestinal malformations including malrotation
have been reported in studies of Shh−/− mice (Ramalho-Santos et al.,
2000). Similar studies have not been replicated in Smo−/− mice as
the knockout results in an embryonic lethal phenotype (Zhang,
Ramalho-Santos, & McMahon, 2001).
The identical recurrent mutation in SMO that accounts for the
multiple malformations in CJS is also observed in several cancers
including ameloblastoma (Sweeney et al., 2014), basal cell carcinoma
(Atwood et al., 2015; Sharpe et al., 2015; Xie et al., 1998),
medulloblastoma (Jones et al., 2012; Pugh et al., 2012), and
meningioma (Brastianos et al., 2013). The mutant protein results in
constitutive activation of smoothened in the absence of HH signaling
in mouse Smo−/− embryonic fibroblasts and is associated with
increased cell division (Sweeney et al., 2014). This finding may help
account for the propensity to develop benign neoplasms such as
smooth muscle hamartomas in affected tissues in the bowel.
TABLE 1 Gastrointestinal features in Curry–Jones syndrome
Patient Case Gender Gastrointestinal featuresa Onsetb Surgeryc
GI myofibromas
or smooth
muscle
hamartomas Recurrenced
Temple et al. (1995) #1 1 M Recurrent pseudo-
obstruction requiring
colostomy, anal stenosis
5 months + Large bowel +
Temple et al. (1995) #2 2 F No symptoms None − Unknown −
Temple et al. (1995) #3 3 M Esophageal dysmotility None − Unknown −
Temple et al. (1995) #4 4 F Constipation; recurrent
massive GI bleeding of
unclear etiology at 10 years
4 months + Mesentery +
Temple et al. (1995) #5 5 M Malrotation; congenital short
gut; obstruction due to
adhesions; severe GERD;
dysmotility of small
intestine; jejunostomy
enteral feeding
8 days + Mesentery +
Mingarelli et al. (1999) 6 M No symptoms None − Unknown −
Thomas et al. (2006) 7 M No symptoms None − Unknown −
Grange et al. (2008) #1 8 M Asymptomatic malrotation
identified on imaging at
9 months; persistent
abdominal distension
Not reported + Large bowel,
mesentery,
retroperitoneum
+
Grange et al. (2008) #2 9 M Malrotation; GERD; pseudo-
obstruction; chronic
constipation; obstipation
and volvulus requiring sub-
total colectomy
<30 days + Large bowel +
Twigg et al. (2016) #8 10 F Malrotation; diarrhea;
malabsorption; pseudo-
obstruction
<30 days + Small bowel and
appendix,
mesentery
+
Present case (Twigg #10) 11 F Malrotation; intestinal
duplication; pseudo-
obstruction; chronic
constipation; gastrostomy
enteral feeding
4 days + Small and large
bowel,
mesentery
+
aPresenting gastrointestinal feature is bolded.
bAge of onset of gastrointestinal symptoms.
cAbdominal surgery for malrotation, pseudo-obstruction, or gastrointestinal bleeding.
dRecurrent gastrointestinal symptoms.
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The mutation in SMO leads to constitutive activation of HH
signaling, hence disrupting the HH pathway in embryonic gastrointes-
tinal development, resulting in gastrointestinal malformations and
impaired peristalsis. The gastrointestinal dysmotility may be due to
aberrant enteric nervous system development in the context of
structural gastrointestinal malformations. The severity of the pheno-
type likely reflects the amount and distribution of the mutant SMO
allele in affected tissues along the gastrointestinal tract.
Clinically, gastrointestinal abnormalities arecommon inCJSandare
a major cause of morbidity in this condition. Table 1 provides
comparison of gastrointestinal features in CJS. In children with known
gastrointestinal abnormalities, onset of symptoms occurred in the
neonatal period in three other cases in addition to the present case.
Gastrointestinal manifestations included structural malformations such
as malrotation (n = 5), congenital short gut (n = 1), and intestinal
duplication (n = 1). One child underwent screening imaging at 9months
of age due to reports of gastrointestinal abnormalities in CJS and was
found tohave an asymptomaticmalrotation (Grange et al., 2008). These
findings highlight the importance of screening abdominal imaging for
gastrointestinal malformations in children with suspected CJS.
Symptoms of underlying gastrointestinal pathology may have
delayed presentation in children with CJS. Beginning at 10 years of
age, one child with CJS had recurrent episodes of bloody stools and
orthostasis requiring hospitalization and multiple blood transfusions
(noted in the table in Grange et al., 2008). During the first episode of
lower gastrointestinal bleeding, she had an exploratory laparotomy
with resection of a Meckel’s diverticulum. Mesenteric smooth muscle
hamartomaswere noted and jejunal biopsy revealed lymphangiectasia.
Another child underwent subtotal colectomy for severe constipation
and volvulus at 10 years of age. Gastrointestinal smooth muscle
hamartomas and benign colonic polyps were noted in the resected
specimen (C. Clericuzio, personal communication, February 6,
2016.). Motility disorders have been observed and have ranged in
severity from chronic constipation (n = 3), small intestine dysmotility
(n = 1), to severe pseudo-obstruction (n = 4), requiring multiple
hospitalizations and colostomy. Children affected with pseudo-
obstruction often required multiple hospitalizations for symptomatic
management and nutritional support and one child underwent
colostomy. Despite surgical intervention, children with CJS and
gastrointestinal abnormalities tend to have recurrent abdominal
symptoms and poor postnatal growth. The prognosis of gastroin-
testinal features is guarded as symptoms often recur or persist
despite surgical intervention. Vigilant and coordinated inter-
disciplinary care with medical, nutritional, and surgical teams is
crucial to mitigate the morbidity due to gastrointestinal abnormali-
ties and optimize postnatal growth.
All cases of CJS in the literature have a distinctive pattern of
malformation allowing clinical diagnosis of this condition. Individuals
newly diagnosed with CJS should have a thorough evaluation to
characterize the degree of gastrointestinal manifestations (see Table 2
for recommended evaluation). This condition probably reflects a high
level of mosaicism in multiple affected tissues. Individuals with lower
level mosaicismmay have less obvious features, particularly cutaneous
features (Khamaysi et al., 2016). The diagnosis of CJS should be
considered in infants with craniosynostosis, polysyndactyly, or patchy
skin manifestations, who have unexplained recurrent gastrointestinal
symptoms.
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